Olympus Her
Olympus Her

Description
Female sexual desire is primarily neurological. Unlike male arousal — which is heavily vascular — women's desire originates in the brain, specifically in hypothalamic pathways that regulate motivation, reward, and emotional safety. This is why Bremelanotide, which activates those exact pathways, was FDA-approved for women and not for men.
Olympus Her pairs Bremelanotide with Oxytocin — the bonding hormone released naturally during intimacy, touch, and orgasm. Women have naturally higher baseline Oxytocin sensitivity than men, meaning the 20IU dose in this formula produces a pronounced effect: reduced anxiety, heightened emotional receptivity, and significantly enhanced orgasm intensity.
There is no Tadalafil in this formula. For women who want the addition of genital blood flow support, Olympus Her+ adds Tadalafil 5mg — the clinically validated female dose. Olympus Her is the pure desire-and-connection formula.
- FDA-approved for premenopausal women with HSDD
- Activates hypothalamic melanocortin receptors (MC3R/MC4R)
- Generates genuine neurological desire — not just physical arousal
- Effective in women unresponsive to hormonal therapy
- Works regardless of hormonal status or relationship duration
- Onset: 30–45 minutes; duration: several hours
- Women have 3x higher baseline Oxytocin sensitivity than men
- Amplifies emotional receptivity and trust
- Reduces performance anxiety and emotional barriers to intimacy
- Significantly enhances orgasm intensity
- Promotes post-intimacy bonding and connection
- Released naturally during touch, intimacy, and orgasm
| Specification | Detail |
|---|---|
| Product Name | Olympus Her |
| SKU | OLY-HER-001 |
| Active Ingredients | Oxytocin 20IU / Bremelanotide 1mg |
| Dosage Form | Sublingual / Buccal Flex-Dose Tablet |
| Quantity per Fill | 12 tablets |
| Refills Available | 3 |
| Target Patient | Women — premenopausal, HSDD, low desire |
| Compounding Pharmacy | Strive Pharmacy |
| Prescription Required | Yes |